(Q73187923)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

High serum osteoprotegerin and low RANKL in primary biliary cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

2 November 2019

main subject

0 references

author name string

Ferenc Szalay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Dalma Hegedus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Peter Laszlo Lakatos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Istvan Tornai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Eva Bajnok

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Kinga Dunkel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Peter Lakatos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

395-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Serum osteoprotegerin and renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Characterization of structural domains of human osteoclastogenesis inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Bone loss and reduced osteoblast function in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Cytokine profile in the liver of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900435-X

7 January 2021

10.1016/S0168-8278(02)00435-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663228%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference